
Sign up to save your podcasts
Or


The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity – The New England Journal of Medicine 2025. Discussion by:
Guest:
Anupryia Grover-Wenk, DO
Resident - Family Medicine Residency Program
Jefferson Health - Abington
2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2
Diabetes. – The New England Journal of Medicine 2025.Discussion by:
Guest:
Samantha Traslaviña, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial. Lancet Rheumatology 2025. Discussion by:
Guest:
Sean Cleary, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
By NACE4.6
2121 ratings
The NACE Journal Club with Dr. Neil Skolnik, provides review and analysis of recently published journal articles important to the practice of primary care medicine. In this episode Dr. Skolnik and guests review the following publications:
1. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity – The New England Journal of Medicine 2025. Discussion by:
Guest:
Anupryia Grover-Wenk, DO
Resident - Family Medicine Residency Program
Jefferson Health - Abington
2. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2
Diabetes. – The New England Journal of Medicine 2025.Discussion by:
Guest:
Samantha Traslaviña, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
3. Cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial. Lancet Rheumatology 2025. Discussion by:
Guest:
Sean Cleary, DO
Resident– Family Medicine Residency Program
Jefferson Health – Abington
Medical Director and Host, Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students as professor of Family and Community Medicine at the Sidney Kimmel Medical College, Thomas Jefferson University and Associate Director, Family Medicine Residency Program at Abington Jefferson Health in Pennsylvania. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and did his residency training at Thomas Jefferson University Hospital in Philadelphia, PA.
This Podcast Episode does not offer CME/CE Credit.
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

978 Listeners

321 Listeners

701 Listeners

124 Listeners

141 Listeners

101 Listeners

298 Listeners

264 Listeners

3,374 Listeners

1,150 Listeners

404 Listeners

95 Listeners